J
Jee Hyun Kim
Researcher at Seoul National University Bundang Hospital
Publications - 703
Citations - 12600
Jee Hyun Kim is an academic researcher from Seoul National University Bundang Hospital. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 46, co-authored 319 publications receiving 9907 citations. Previous affiliations of Jee Hyun Kim include Seoul National University & New Generation University College.
Papers
More filters
Journal ArticleDOI
HER2/CEP17 ratio and HER2 immunohistochemistry predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 fluorescence in situ hybridization-positive metastatic breast cancer
Ji Won Kim,Ji Won Kim,Jee Hyun Kim,Seock-Ah Im,Seock-Ah Im,Yu Jung Kim,Hye Suk Han,Jin Soo Kim,Kyung Hun Lee,Kyung Hun Lee,Tae Yong Kim,Tae Yong Kim,Sae-Won Han,Sae-Won Han,Yoon Kyung Jeon,Yoon Kyung Jeon,Do Youn Oh,Do Youn Oh,Tae-You Kim,Tae-You Kim,In Ae Park,In Ae Park +21 more
TL;DR: The data support that HER2/CEP17 ratios and HER2 IHC scores may predict clinical outcome after first-line trastuzumab plus taxane chemotherapy in patients with HER2 FISH-positive MBC.
Journal ArticleDOI
Phase II Trial of Low-dose Paclitaxel and Cisplatin in Patients with Advanced Gastric Cancer
Keun Wook Lee,Seock-Ah Im,Tak Yun,Eun Kee Song,Im Il Na,Hyunchoon Shin,In Sil Choi,Do Youn Oh,Jee Hyun Kim,Dong Wan Kim,Tae-You Kim,Jong-Seok Lee,Dae Seog Heo,Yung-Jue Bang,Noe Kyeong Kim +14 more
TL;DR: This regimen seems to have comparable efficacy to previously reported higher-dose paclitaxel plus cisplatin-containing regimens and fewer toxicities in chemotherapy-naïve gastric cancer patients.
Journal ArticleDOI
The outcomes of concomitant chemoradiotherapy followed by adjuvant chemotherapy with temozolomide for newly diagnosed high grade gliomas : the preliminary results of single center prospective study.
TL;DR: Preliminary results of the treatment with CCRT with TMZ of newly diagnosed malignant gliomas in Korean people are consistent with many other reports, confirming that CCRt with TMZ achieves good clinical outcomes in the treatment of HGG.
Journal ArticleDOI
Quality of life (QoL) in metastatic breast cancer patients with maintenance paclitaxel plus gemcitabine (PG) chemotherapy: results from phase III, multicenter, randomized trial of maintenance chemotherapy versus observation (KCSG-BR07-02).
Yeon Hee Park,Kyung Hae Jung,Seock-Ah Im,Joohyuk Sohn,Jungsil Ro,Jin-Hee Ahn,Sung Bae Kim,Byung-Ho Nam,Do Youn Oh,Sae-Won Han,Soohyeon Lee,In Hae Park,Keun Seok Lee,Jee Hyun Kim,Seok Yun Kang,Moon Hee Lee,Hee Sook Park,Sook Young Woo,Sin-Ho Jung,Jin Seok Ahn,Young-Hyuck Im +20 more
TL;DR: Examination of QoL among women with MBC treated on KCSG-BR07-02 with maintenance of paclitaxel plus gemcitabine (PG) chemotherapy after achieving disease control to initial six cycles of PG chemotherapy or observation found maintenance PG chemotherapy resulted in better PFS and OS compared to observation without impedingQoL.
Journal ArticleDOI
Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
Chanbin Lee,Jieun Kim,Jinsol Han,Dayoung Oh,MinJu Kim,Hayeong Jeong,Tae-Jin Kim,Sang-Woo Kim,Jeong Nam Kim,Young-Su Seo,Ayako Suzuki,Jee Hyun Kim,Young-Doo Jung +12 more
TL;DR: This article showed that FPR2 mediates sex-specific responses to diet-induced NASH-like liver injury in both sexes during choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD) feeding, but compared with females, male mice had more severe hepatic damage.